The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Credit: US Food and Drug Administration
Semaglutide (Wegovy) Receives FDA Label Expansion to Include Cardiovascular Risk Reduction

March 8th 2024

On March 08, 2024, the FDA approved semaglutide 2.4 mg (Wegovy) to reduce cardiovascular risk in adults with obesity or overweight and heart disease based on the SELECT trial.

Risa M. Wolf, MD | Image Credit: Johns Hopkins University School of Medicine
CGM Use in Type 1 Diabetes Management May Mitigate Risk of Retinopathy

March 7th 2024

Stock imagery of a body weight scale. | Credit: iStock
Novo Nordisk Delivers Updates on Development of Semaglutide, CagriSema, Amycretin, and More

March 7th 2024

Endocrinology month in review February 2024 thumbnail
Endocrinology Month in Review: February 2024

March 6th 2024

Elizabeth Pearce, MD, MSc | Credit: Boston Medical Center
Thyroidectomy, Radioactive Iodine Could Prevent More CV Events than Antithyroid Drugs

March 6th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.